FDA InspectionAurobindo Pharma USA Inc
Aurobindo Pharma USA Inc – FDA Inspection, Jul 29, 2011
Record Details
This FDA Inspection record concerns Aurobindo Pharma USA Inc, with an inspection on July 29, 2011, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Aurobindo Pharma USA Inc
- Inspection Date
- July 29, 2011
- Product Type
- Drugs
ID · bacfcc10-9940-4b19-9084-4bb60639c9f3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 736360
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
6- 21 CFR 314.80(b)Failure to review ADE information
- 21 CFR 314.81(b)(1)(ii)Contamination, chemical or physical change, deterioration
- 21 CFR 314.80(c)(1)(ii)Submission of report follow-up
- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Aurobindo Pharma USA Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 4, 2026 | Not classified | New Jersey District Office | |
| May 15, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 30, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Or discuss it with
What you get
A document
One file.
- One FDA document, such as a Form 483
- Yours for life in your Library
- Each has its own price
The profile
All the documents, plus intelligence about the company.
- Every Aurobindo Pharma USA Inc document on file
- The KRA score, which a single document does not include
- Observations and inspection history
Access
This, for every company on KeyPedia.
- Combine profiles in one search
- Search across any modality: products, industry types, drugs, devices and recalls
- Track everything as it changes
- Other agencies too, such as EMA, Health Canada and UK MHRA